Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene Symbol | SETD3 | ||||||||||
Synonyms | C14orf154 | hSETD3 | ||||||||||
Gene Description | SETD3, SET domain containing 3, actin N3(tau)-histidine methyltransferase, encodes a chromatin modifier that retains cytoskeleton integrity through actin methylation (PMID: 30526847, PMID: 30626964, PMID: 34685411), and plays a role in regulating gene transcription in muscle cell differentiation through methylation of H3K4 and H3K6 (PMID: 21832073) and negative regulation of VEGF expression (PMID: 27845446, PMID: 29950684). A SETD3 fusion with ALK has been identified in lung adenocarcinoma (PMID: 36495785) and increased SETD3 expression has been identified in several tumor types (PMID: 33157163), including hepatocellular carcinoma (PMID: 31654063) and renal cell carcinoma (PMID: 26488939). | ||||||||||
|